Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin family pseudogene 1 (ACTP1) is a processed pseudogene located on chromosome 2q12.3. It belongs to the actin family, which contains many protein-coding members (such as ACTA1, ACTB, ACTG1) responsible for critical cellular activities including muscle contraction, cell structure maintenance, and motility; however, ACTP1 itself does not encode a functional protein and is not known to participate in any cellular processes or disease mechanisms. Pseudogenes like ACTP1 may arise during evolution through duplication or retrotransposition events, but most do not produce functional products. There is no evidence ACTP1 is a therapeutic target, nor is it associated with any drugs, disease, or biomarker use. ACTP1 should not be confused with functional actin family genes (e.g., ACTA1, ACTB), which are biologically important and can be associated with disease. The existence of ACTP1 as a pseudogene means it does not encode a functional receptor, enzyme, transporter, or any typical druggable protein class.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin family pseudogene 1 (ACTP1).